Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axonics Inc (NQ: AXNX )

67.72 +0.23 (+0.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 176,852
Open 67.50
Bid (Size) 67.70 (2)
Ask (Size) 67.72 (1)
Prev. Close 67.49
Today's Range 67.38 - 67.72
52wk Range 48.30 - 69.68
Shares Outstanding 46,134,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
From Axonics, Inc.
Via Business Wire
AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024
AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+13.41%
+13.41%
1 Month
+1.01%
+1.01%
3 Month
-0.04%
-0.04%
6 Month
-1.93%
-1.93%
1 Year
+35.33%
+35.33%

More News

Read More
Axonics Reports First Quarter 2024 Financial Results
From Axonics, Inc.
Via Business Wire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Via MarketBeat
Beyond The Numbers: 7 Analysts Discuss Axonics Stock
Via Benzinga
Analyst Scoreboard: 5 Ratings For Axonics
Via Benzinga
Why Axonics Stock Soared Today
Via The Motley Fool
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Via Benzinga
Exposures Product Safety
Axonics Stockholders Approve Merger Agreement with Boston Scientific
From Axonics, Inc.
Via Business Wire
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Axonics Responds to ITC Action by Medtronic
From Axonics, Inc.
Via Business Wire
Health Care Company Boston Scientific Announces Acquisition of Axonics
Via Benzinga
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From Axonics, Inc.
Via Business Wire
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
From Kahn Swick & Foti, LLC
Via Business Wire
Why Medical Devices Giant Boston Scientific Shares Are Rising Today
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
Via Investor's Business Daily
Topics ETFs
Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
Via Benzinga
10 Top Stocks With a Strong Buy Rating Right Now
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Is Crocs (CROX) Stock Up 20% Today?
Via InvestorPlace
Why Is Axonics (AXNX) Stock Up 20% Today?
Via InvestorPlace
Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.